Analyst Price Targets — ITGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 2:06 pm | — | Truist Financial | $110.00 | $98.50 | TheFly | Integer price target raised to $110 from $97 at Truist |
| May 13, 2026 10:22 am | Suraj Kalia | Oppenheimer | $115.00 | $84.98 | TheFly | Oppenheimer upgrades Integer to Outperform as checks suggest PE CMO interest |
| February 23, 2026 2:40 pm | — | Raymond James | $101.00 | $84.95 | TheFly | Integer price target raised to $101 from $95 at Raymond James |
| December 18, 2025 2:11 pm | Richard Newitter | Truist Financial | $95.00 | $80.60 | TheFly | Integer price target raised to $95 from $86 at Truist |
| November 24, 2025 1:41 pm | — | Truist Financial | $86.00 | $69.61 | TheFly | Integer price target lowered to $86 from $88 at Truist |
| October 24, 2025 1:19 pm | — | Truist Financial | $88.00 | $73.89 | TheFly | Integer price target lowered to $88 from $121 at Truist |
| October 24, 2025 12:35 pm | Matt O'Brien | Piper Sandler | $82.00 | $73.89 | StreetInsider | Integer Holding (ITGR) PT Lowered at Piper Sandler as 'Soft 2026 Sales Outlook Steals Investor Focus' |
| October 24, 2025 12:27 pm | — | Raymond James | $95.00 | $73.89 | TheFly | Integer price target lowered to $95 from $143 at Raymond James |
| October 21, 2025 10:42 am | Brett Fishbin | KeyBanc | $133.00 | $107.37 | TheFly | Integer price target lowered to $133 from $145 at KeyBanc |
| October 15, 2025 12:36 pm | — | Truist Financial | $121.00 | $104.27 | TheFly | Integer price target lowered to $121 from $137 at Truist |
Latest News for ITGR
PLANO, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today that it will webcast its conference call to discuss financial results and business highlights for the second quarter ended July 3, 2026, on Thursday, Aug. 6, 2026, at 8 a.m. CT (9 a.m. ET). Other forward-looking and…
ITGR resets its 2026 outlook after customer forecast changes and slower product ramps, with growth and margin recovery tied to adoption timing.
PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation in the Truist Securities 2026 MedTech Conference, to be held June 16, 2026. Members of the Integer executive leadership team will participate in a fireside chat on Tuesday, June 16 at 10:40 a.m. ET.
There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.
Integer Holdings Corp. is a unique, high-quality medical device CDMO trading at a depressed ~10x EBITDA multiple after a temporary growth slowdown. A strategic review, prompted by activist involvement and heightened buyer interest, positions ITGR for a likely sale within three to four months. Precedent CDMO transactions support a fair value of $110–125/share (13–14x forward EBITDA), offering 20–40% upside with…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ITGR.
U.S. House Trading
No House trades found for ITGR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.